Diagnosis, Healthcare, Manufacturing and Provider

The Healthcare Vision of ChatGPT-4o and Multimodal LLMs

The Medical Futurist

JUNE 21, 2025

Large language models will soon find their way in to everyday clinical settings , simply because the global shortage of healthcare personnel is becoming dire and AI will lend a hand with tasks that do not require skilled medical professionals. Current medical AIs only process one type of data, for example, text or X-ray images.

Healthcare

Healthcare Healthcare Professional Electronics Medical

9 Technologies That Will Shape The Future Of Dentistry

The Medical Futurist

JUNE 17, 2025

For dentists, it’s transforming diagnosis, decision-making, and treatment planning. Smart toothbrush While AI helps dental professionals provide better treatments, smart toothbrushes enable all of us to take better care of our teeth. For patients, it promises more accurate care and better outcomes.

Patients

Patients Treatment Plan Healthcare Medical Specialty

The Future Of Vision And Eye Care

The Medical Futurist

JUNE 21, 2025

Researchers say that the implant cannot provide any highly detailed vision – but it can help patients detect distinct patterns such as door frames and shapes. The journal Nature provided a commentary report on HKUST’s research into the bionic eye. The paper, recently published in PLOS , summarises three years of data.

Diabetes

Diabetes Patient-Centered IT Patients

Proposed LDT Rule Raises Many Questions but Provides Few Answers

FDA Law

OCTOBER 6, 2023

The crux of the proposed rule lies in the addition of ten words: “ including when the manufacturer of these products is a laboratory.” These words would be added to the definition of “ in vitro diagnostic [IVD] products” in 21 C.F.R. In addition, FDA proposes to continue to exercise enforcement discretion (i.e.,

Provider

Provider Manufacturing IT Medical

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

FDA Law

AUGUST 23, 2022

These practical benefits are in marked contrast to molecular COVID-19 tests that are used for definitive diagnosis and are generally expected to detect the SARS-CoV-2 virus at least 95% of the time when someone is infected. After two negative tests, you should consider a molecular test, or call your healthcare provider.

Individual

Individual Clinic Healthcare Provider

Out At Home: FDA’s Vocal Support of Home Testing but Reluctance to Clear Novel OTC Home Tests

FDA Law

JUNE 22, 2023

To obtain clearance of an OTC home IVD, a sponsor must provide the usual suite of analytical and clinical validation that would be required for any IVD, demonstrating adequate repeatability, stability, sensitivity, specificity, and so on. HbA1c, diagnosis of a particular virus, etc.). seeking treatment).

Manufacturing

Manufacturing Clinic IT Transportation

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

JUNE 20, 2024

Accreditation In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IT

IT Patient-Centered Patients Clinic

It Takes Three [Components] to Make a Thing Go Riiiiiight – OPDP Challenges Two-Part Ad

FDA Law

JANUARY 26, 2022

This content is likely one of the reasons for FDA’s withdrawal of the Draft Guidance in 2015 – the same year that FDA suffered one of the most significant blows regarding First Amendment protections for pharmaceutical manufacturer speech.

IT

IT Education Utilities Patient-Centered

Where Are All the OTC Rapid Antigen Tests for COVID? FDA’s Role in Blocking These Tests from the American Market

FDA Law

NOVEMBER 18, 2021

Rapid tests for COVID-19 are fast, inexpensive to manufacture, and a relatively easy method to detect the presence of an active SARS?CoV?2 PCR) test is considered the gold standard for actual diagnosis. True, these tests will never provide the same diagnostic quality results as RT?PCR, Why is that? Background. 2 infection.

Screening

Screening Manufacturing Healthcare IT

New Breakthrough Devices Program Guidance: Expanding Opportunities for Medical Product Innovations

FDA Law

OCTOBER 17, 2023

Compared to the previous version, the new guidance document highlights that the Breakthrough Devices Program may also be applicable to certain devices that benefit populations impacted by health and/or healthcare disparities and to certain non-addictive medical products to treat pain or addiction.

Medical

Medical Diagnosis Healthcare Clinic

Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled

FDA Law

JANUARY 18, 2024

whether growing or not; its seeds; resin extracted from any part; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. “Marijuana,” subject to the rescheduling recommendation, means all parts of the plant Cannabis sativa L., 21 U.S.C. § 802(16)(A). 21 U.S.C. § 802(16)(B).

Medical

Medical Physicals IT Healthcare Professional

Primary Care Digest

The Healthcare Vision of ChatGPT-4o and Multimodal LLMs

9 Technologies That Will Shape The Future Of Dentistry

Trending Sources

The Future Of Vision And Eye Care

Proposed LDT Rule Raises Many Questions but Provides Few Answers

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

Out At Home: FDA’s Vocal Support of Home Testing but Reluctance to Clear Novel OTC Home Tests

Urinary Incontinence Revisited: George Kuchel & Alison Huang

It Takes Three [Components] to Make a Thing Go Riiiiiight – OPDP Challenges Two-Part Ad

Where Are All the OTC Rapid Antigen Tests for COVID? FDA’s Role in Blocking These Tests from the American Market

New Breakthrough Devices Program Guidance: Expanding Opportunities for Medical Product Innovations

Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled

Stay Connected